• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

    1.200 -0.460 (-27.72%)
    Streaming Delayed Price Updated: 11:34 AM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,244,319
    Open 1.600
    Bid (Size) 1.190 (1,300)
    Ask (Size) 1.200 (1,500)
    Prev. Close 1.660
    Today's Range 1.165 - 1.630
    52wk Range 0.6200 - 4.310
    Shares Outstanding 124,094,390
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Which stocks are gapping on Tuesday? ↗
    Via Chartmill
    News headline image
    Nautilus Biotechnology Q2 Earnings Call Highlights ↗
    Nautilus Biotechnology (NASDAQ:NAUT) said it is shifting a significant share of its research and development resources toward proteoform applications, citing customer interest and a delay in its... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    -37.2%
    -37.2%
    1 Month
    -33.0%
    -33.0%
    3 Month
    -53.3%
    -53.3%
    6 Month
    -40.9%
    -40.9%
    1 Year
    +53.4%
    +53.4%

    More News

    Read More
    News headline image
    Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway ↗
    Via Chartmill
    News headline image
    Nautilus (NAUT) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Nautilus Biotechnology Reports First Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard ↗
    Via InvestorPlace
    Topics Artificial Intelligence Economy Initial Public Offering
    News headline image
    Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Q1 Virtual Investor Summit Presentations Now Available On Demand
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus (NAUT) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?
    Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.
    What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?
    Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?
    The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market
    What is the current price of Nautilus Biotechnology, Inc. - Common Stock?
    The current price of Nautilus Biotechnology, Inc. - Common Stock is 1.200
    When was Nautilus Biotechnology, Inc. - Common Stock last traded?
    The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 07/28/26 11:34 AM ET
    What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?
    The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 148.90M
    How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?
    Nautilus Biotechnology, Inc. - Common Stock has 149M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.